BSE filing, NSE: BABA. Summary written from the filing by ALFA Finder's alert engine.
Baba Arts Ltd: key numbers
- Share price
- ₹25.61
- Market cap
- ₹134.4 Cr
- Revenue (annual)
- ₹14.95 Cr
- Net profit (annual)
- ₹0.65 Cr
- P/E (TTM)
- 296.4×Sector 27.7×
- Promoter holding
- 74.68%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Baba Arts Ltd
All →Baba Arts Annual General Meeting
Baba Arts Limited reported the outcome of its 27th AGM held on 3 November 2026 via video conferencing. All notice resolutions, including adoption of accounts and director appointments, were approved by majority.
Baba Arts Other Announcement
Gordhan P. Tanwani transferred 65,00,000 shares to Skybridge Interactive LLP off-market on 3 November 2026. The PIT Regulation 7(2) disclosure states no transaction price.
Baba Arts Promoter Selling (Off-Market): ₹3.9 Cr
Promoter Gordhan Tanwani completed the off-market transfer of 65 lakh Baba Arts shares to Skybridge Interactive LLP. The final tranche is valued at Rs 3.90 Crore.
- Value
- ₹3.90 Cr
Baba Arts Q2 FY27 Results: Net Profit ₹0.2 Cr, Down 50.0% YoY
Baba Arts Ltd reported net profit of ₹0.2 Cr (-50.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.2 Cr · -50.0% YoY
Baba Arts Other Announcement
Baba Arts Ltd disclosed KMPs authorised for Reg 30(5) LODR disclosures. This is a routine compliance intimation with no business or financial impact.
Baba Arts Annual General Meeting
Baba Arts Limited issued a corrigendum to the notice of its 27th Annual General Meeting scheduled for November 3, 2026, correcting typographical errors.
Other capital structure change announcements
All →Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.
- Value
- ₹40.00 Cr
Dr. Lal Pathlabs Capital Structure Change
Dr. Lal PathLabs will invest up to Rs 49.5 Crore in its wholly owned Dubai subsidiary, in tranches. Funds cover operations and further investment in Ghana's SHL.
- Value
- ₹49.50 Cr
- Execution
- Indicative completion by 31 March 2027, in tranches
Atul Capital Structure Change
Atul bought back 4,100 equity shares on 4 November 2026 for ₹2.09 Crore. Cumulative buyback utilisation stands at ₹10.82 Crore of ₹90 Crore earmarked.
- Value
- ₹2.09 Cr
Jenburkt Pharmaceuticals Capital Structure Change
Counter Cyclical Investments Private Limited acquired 4,608 equity shares of Jenburkt Pharmaceuticals Ltd through the open market. This acquisition increased the acquirer's total holding from 5.01% to 5.11%.